ATE229983T1 - Maspin- ein neues serpin mit tumor unterdrückender aktivität - Google Patents

Maspin- ein neues serpin mit tumor unterdrückender aktivität

Info

Publication number
ATE229983T1
ATE229983T1 AT93921337T AT93921337T ATE229983T1 AT E229983 T1 ATE229983 T1 AT E229983T1 AT 93921337 T AT93921337 T AT 93921337T AT 93921337 T AT93921337 T AT 93921337T AT E229983 T1 ATE229983 T1 AT E229983T1
Authority
AT
Austria
Prior art keywords
maspin
suppressing activity
tumor suppressing
serpin
new
Prior art date
Application number
AT93921337T
Other languages
English (en)
Inventor
Ruth Sager
Zhiqiang Zou
Anthony Anisowicz
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE229983T1 publication Critical patent/ATE229983T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93921337T 1992-09-01 1993-09-01 Maspin- ein neues serpin mit tumor unterdrückender aktivität ATE229983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93882392A 1992-09-01 1992-09-01
PCT/US1993/008322 WO1994005804A1 (en) 1992-09-01 1993-09-01 Maspin, a novel serpin with tumor suppressing activity

Publications (1)

Publication Number Publication Date
ATE229983T1 true ATE229983T1 (de) 2003-01-15

Family

ID=25472030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921337T ATE229983T1 (de) 1992-09-01 1993-09-01 Maspin- ein neues serpin mit tumor unterdrückender aktivität

Country Status (6)

Country Link
EP (1) EP0662150B1 (de)
JP (1) JP3489629B2 (de)
AT (1) ATE229983T1 (de)
CA (1) CA2143188A1 (de)
DE (1) DE69332583T2 (de)
WO (1) WO1994005804A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
JP2002085093A (ja) * 2000-09-08 2002-03-26 Kuo Kwang Biotech Corp 扁平上皮細胞癌患者の生存予測
WO2007095583A2 (en) * 2006-02-14 2007-08-23 Children's Memorial Research Center Methods for treating cancer and sensitizing cancer cells using the serine protease inhibitor, maspin
WO2018017454A1 (en) * 2016-07-20 2018-01-25 The Lubrizol Corporation Alkyl phosphate amine salts for use in lubricants
KR102179381B1 (ko) * 2018-12-28 2020-11-16 주식회사 네오젠티씨 Mal이 발현된 줄기세포 유사 기억 t 세포를 유효성분으로 포함하는 면역증강 또는 항암활성 증진용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
WO1992015602A1 (en) * 1991-02-28 1992-09-17 Dana-Farber Cancer Institute, Inc. Cancer diagnosis and therapy

Also Published As

Publication number Publication date
JPH08500977A (ja) 1996-02-06
DE69332583T2 (de) 2003-11-20
EP0662150B1 (de) 2002-12-18
JP3489629B2 (ja) 2004-01-26
CA2143188A1 (en) 1994-03-17
WO1994005804A1 (en) 1994-03-17
EP0662150A4 (de) 1997-01-29
EP0662150A1 (de) 1995-07-12
DE69332583D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
AU601144B2 (en) Cytotoxic protein
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
NO913211L (no) Nytt monoklonalt antistoff mot nytt antigen knyttet til menneske-tumorer.
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
DE69434538D1 (de) Vaskularer endothelialer wachstumsfaktor 2
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
CA2108473A1 (en) Heregulins (hrgs) binding proteins of p185erb2
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
HK1008021A1 (en) Growth hormone receptor
DE69428214T2 (de) Transformierender wachstumsfaktor alpha h1
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE68925226D1 (de) Monoklonale Antikörper
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
Van Damme et al. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
Ando et al. Natural human interferon‐γ derived from lipopolysaccharide‐stimulated human myelomonocytic HBL‐38 cells
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ATE195342T1 (de) Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie
DK193187D0 (da) Interferoninduceret humanprotein paa ren form, dets fremstilling og anvendlese
Roman Jr et al. Studies on the Molecular Basis for C1̄s Action and Comparison of C1̄s with Other Tryptic Proteases
JPS6410998A (en) Tumor cell inhibitory factor
Yasuda et al. Partial purification and characterization of feline gamma-like interferon
EA199900663A1 (ru) Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties